4//SEC Filing
SAVIENT PHARMACEUTICALS INC 4
Accession 0001230295-05-000072
CIK 0000722104operating
Filed
May 18, 8:00 PM ET
Accepted
May 19, 9:14 AM ET
Size
9.8 KB
Accession
0001230295-05-000072
Insider Transaction Report
Form 4
Gyenes Lawrence A
SVP, Chief Financial Officer
Transactions
- Purchase
Common Stock, $.01 par value per share
2005-05-17$3.08/sh+9,100$28,028→ 39,600 total - Purchase
Common Stock, $.01 par value per share
2005-05-17$3.06/sh+3,900$11,934→ 43,500 total - Purchase
Common Stock, $.01 par value per share
2005-05-17$3.09/sh+900$2,781→ 44,400 total - Purchase
Common Stock, $.01 par value per share
2005-05-17$3.07/sh+1,100$3,377→ 30,500 total
Documents
Issuer
SAVIENT PHARMACEUTICALS INC
CIK 0000722104
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000722104
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 9:14 AM ET
- Size
- 9.8 KB